Cleared Traditional

K830611 - RA SCREENING TEST

K830611 is an FDA 510(k) clearance for RA SCREENING TEST, manufactured by Tago, Inc.. The device is a Class 2 Immunology device with product code DHR cleared through the Traditional 510(k) pathway after a 24-day FDA review.

K830611 · Tago, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1983
Decision
24d
Days
Class 2
Risk

K830611 is an FDA 510(k) clearance for the RA SCREENING TEST. Classified as System, Test, Rheumatoid Factor (product code DHR), Class II - Special Controls.

Submitted by Tago, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 24, 1983 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5775 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tago, Inc. devices

FDA 510(k) Submission Details - K830611

510(k) Number K830611 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 1983
Decision Date March 24, 1983
Days to Decision 24 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 105d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHR Device Classification - Class 2, Special Controls

Product Code DHR System, Test, Rheumatoid Factor
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5775
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHR System, Test, Rheumatoid Factor

All 114
Devices cleared under the same product code (DHR) and FDA review panel - the closest regulatory comparables to K830611.
SERO/TEX RED CELL RF TEST
K831597 · Texas Immunology, Inc. · Jun 1983
RA-CHECK
K831467 · Diagnostic Technology, Inc. · Jun 1983
RHEUMATOID FACTOR-RAPID CARD TEST #65114
K830832 · Emd Chemicals, Inc. · Apr 1983
LATEST RF KIT FOR RHEUMATOID FACTOR
K822905 · Fisher Scientific Co., LLC · Oct 1982
RHEUMATOID FACTOR REFERENCE PREPARA.
K821941 · Armkel, LLC · Aug 1982
SERO/TEX RF TEST
K821319 · Texas Immunology, Inc. · May 1982